In 2020, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion was one aim of the ACR Convergence 2020 session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts had to say.
Ethan Craig, MD, MHS, an assistant professor of clinical medicine with the Division of Rheumatology at the University of Pennsylvania, Philadelphia, a rheumatologist at the Corporal Michael J. Crescenz VA Medical Center and the associate physician editor of The Rheumatologist, reviewed the research abstracts related to gout presented at ACR Convergence 2020 and talks about why they stand out.
Below, explore our coverage of additional gout information presented at ACR Convergence 2020, selected by Physician Editor Philip Seo, MD, MHS, as well as selected content from The Rheumatologist’s collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout.
Added May 5, 2021: Video—Validation of Proposed Remission and Completion Criteria for Gout Treatment.
Featured: Study Probes Using Pegloticase with Mycophenolate Mofetil in Refractory Gout
Click here to view enhanced content
Click here to view visual abstract summary
